| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Net loss | ||||||||
-49,152 | -45,513 | -34,599 | -28,166 | -22,916 | -16,521 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Stock-based compensation expense | ||||||||
7,177 | 6,171 | 4,915 | 3,774 | 571 | 272 | 0 | 0 | 0 |
Amortization of operating lease right-of-use assets | ||||||||
0 | - | - | - | - | - | - | - | - |
Non-cash interest expense | ||||||||
- | - | - | - | - | 1,642 | 0 | 0 | 0 |
Change in fair value of derivative liability | ||||||||
- | - | - | - | - | 972 | 0 | 0 | 0 |
Change in fair value of warrant liability | ||||||||
- | - | - | - | - | 168 | 0 | 0 | 0 |
Change in operating lease liability | ||||||||
0 | - | - | - | - | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||
Prepaid expenses | ||||||||
7,556 | 5,922 | 2,784 | 4,651 | 1,170 | 1,179 | 0 | 0 | 0 |
Accounts payable | ||||||||
-1,082 | 5,751 | -858 | 2,634 | 1,926 | 2,302 | 0 | 0 | 0 |
Accrued expenses and other current liabilities | ||||||||
2,642 | 3,401 | 3,056 | 772 | 2,001 | 941 | 0 | 0 | 0 |
Net cash used in operating activities | ||||||||
-48,160 | -36,307 | -29,769 | -23,950 | -17,053 | -11,182 | 0 | 0 | 0 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Purchase of available-for-sale securities | ||||||||
0 | - | - | - | - | - | - | - | - |
Net cash used in investing activities | ||||||||
0 | - | - | - | - | - | - | - | - |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Proceeds from issuance of Series B convertible preferred stock, net of cash issuance costs of $186 | ||||||||
- | - | - | - | 0 | - | - | - | - |
Proceeds from secondary public offering, net of cash issuance costs of $702 | ||||||||
0 | - | - | - | - | - | - | - | - |
Payment of deferred offering costs | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Proceeds from issuance of convertible promissory notes, net of cash issuance costs of $440 | ||||||||
- | - | - | - | - | 5,560 | 0 | 0 | 0 |
Exercise of stock options for common stock under Equity Incentive Plan | ||||||||
0 | - | - | - | - | - | - | - | - |
Net cash provided by financing activities | ||||||||
187,694 | 56,415 | 59,151 | 59,473 | 24,033 | 26,653 | 0 | 0 | 0 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | ||||||||
77,817 | 102 | 9,504 | 35,523 | 6,980 | 15,471 | 0 | 0 | 0 |
Issuance of warrants | ||||||||
- | - | - | - | 0 | - | - | - | - |
Derivative liability in connection with issuance of convertible promissory notes | ||||||||
- | - | - | - | - | 1,896 | 0 | 0 | 0 |
Private offering costs in accrued expenses | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Secondary offering costs in accounts payable | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Unrealized gain (loss) on marketable securities | ||||||||
0 | - | - | - | - | - | - | - | - |
2018 Notes | ||||||||
Issuance of warrants | ||||||||
- | - | - | - | - | - | - | 0 | 0 |